A drug that combines an atypical antipsychotic and an SSRI is under FDA review, and if approved will be the first ...

A scientist at the Salk Institute in La Jolla is hoping to develop a new anti-anxiety drug that would help you "focus, breathe and center." Dr. Sung Han, an associate professor at Salk ...

Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing impurities.

Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side ...

ITI-1284 is under clinical development by Intra-Cellular Therapies and currently in Phase II for Generalized Anxiety Disorder (GAD).

A new study conducted by researchers at the University of Waterloo analyzed data from nearly 500,000 Canadian patients who ...

Medication Management Physician treating ADHD, insomnia, anxiety & mild depression, young adult, women's health. Dr. Chikvashvili is a double board certified child & adult psychiatrist in New York ...